The role of mitochondria in the pathogenesis of type 2 diabetes.

PubWeight™: 2.59‹?› | Rank: Top 1%

🔗 View Article (PMC 3365846)

Published in Endocr Rev on February 15, 2010

Authors

Mary-Elizabeth Patti1, Silvia Corvera

Author Affiliations

1: Research Division, Joslin Diabetes Center, Boston, Massachusetts 02215, USA. mary.elizabeth.patti@joslin.harvard.edu

Associated clinical trials:

Bioenergetics and Metabolism in Pediatric Populations | NCT03323294

Articles citing this

(truncated to the top 100)

Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J Exp Med (2011) 2.35

Identification of a protein mediating respiratory supercomplex stability. Cell Metab (2012) 1.95

Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle. Cell Metab (2014) 1.72

Chlorinated persistent organic pollutants, obesity, and type 2 diabetes. Endocr Rev (2014) 1.71

Pharmacological approaches to restore mitochondrial function. Nat Rev Drug Discov (2013) 1.66

Development of insulin resistance in mice lacking PGC-1α in adipose tissues. Proc Natl Acad Sci U S A (2012) 1.61

Reactive oxygen species in health and disease. J Biomed Biotechnol (2012) 1.52

Cellular metabolic and autophagic pathways: traffic control by redox signaling. Free Radic Biol Med (2013) 1.46

Defects in muscle branched-chain amino acid oxidation contribute to impaired lipid metabolism. Mol Metab (2016) 1.38

What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes (2012) 1.35

Adipose-specific deletion of TFAM increases mitochondrial oxidation and protects mice against obesity and insulin resistance. Cell Metab (2012) 1.32

Mitochondrial dysfunction in white adipose tissue. Trends Endocrinol Metab (2012) 1.22

Mitochondrial dysfunction in patients with primary congenital insulin resistance. J Clin Invest (2011) 1.19

Metabolic network topology reveals transcriptional regulatory signatures of type 2 diabetes. PLoS Comput Biol (2010) 1.18

Chronic enrichment of hepatic endoplasmic reticulum-mitochondria contact leads to mitochondrial dysfunction in obesity. Nat Med (2014) 1.18

Comparative plasma lipidome between human and cynomolgus monkey: are plasma polar lipids good biomarkers for diabetic monkeys? PLoS One (2011) 1.14

Early Pregnancy Maternal Blood DNA Methylation in Repeat Pregnancies and Change in Gestational Diabetes Mellitus Status—A Pilot Study. Reprod Sci (2015) 1.12

Exploring the therapeutic space around NAD+. J Cell Biol (2012) 1.09

Obese adipocytes show ultrastructural features of stressed cells and die of pyroptosis. J Lipid Res (2013) 1.09

Evidence for the intra-uterine programming of adiposity in later life. Ann Hum Biol (2011) 1.06

Apelin treatment increases complete Fatty Acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice. Diabetes (2011) 1.05

IL-6 induces lipolysis and mitochondrial dysfunction, but does not affect insulin-mediated glucose transport in 3T3-L1 adipocytes. J Bioenerg Biomembr (2011) 1.04

Msp1/ATAD1 maintains mitochondrial function by facilitating the degradation of mislocalized tail-anchored proteins. EMBO J (2014) 1.04

Relation of mitochondrial oxygen consumption in peripheral blood mononuclear cells to vascular function in type 2 diabetes mellitus. Vasc Med (2014) 1.00

Sites of superoxide and hydrogen peroxide production during fatty acid oxidation in rat skeletal muscle mitochondria. Free Radic Biol Med (2013) 1.00

Mitochondrial uncoupling proteins and energy metabolism. Front Physiol (2015) 1.00

Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways. Diabetes (2010) 0.99

Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement. PLoS One (2011) 0.98

Mitochondrial dysregulation in the pathogenesis of diabetes: potential for mitochondrial biogenesis-mediated interventions. Exp Diabetes Res (2011) 0.98

Fructose: a key factor in the development of metabolic syndrome and hypertension. J Nutr Metab (2013) 0.97

Enhanced cardiac protein glycosylation (O-GlcNAc) of selected mitochondrial proteins in rats artificially selected for low running capacity. Physiol Genomics (2012) 0.96

Mitonuclear interactions: evolutionary consequences over multiple biological scales. Philos Trans R Soc Lond B Biol Sci (2014) 0.96

Interaction between mitochondria and the endoplasmic reticulum: implications for the pathogenesis of type 2 diabetes mellitus. Exp Diabetes Res (2011) 0.96

Mitochondrial metabolism of pyruvate is essential for regulating glucose-stimulated insulin secretion. J Biol Chem (2014) 0.96

Mitochondrial calcium homeostasis as potential target for mitochondrial medicine. Mitochondrion (2011) 0.96

Translating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitine. Transl Res (2012) 0.95

Crif1 deficiency reduces adipose OXPHOS capacity and triggers inflammation and insulin resistance in mice. PLoS Genet (2013) 0.95

Adipose tissue angiogenesis: impact on obesity and type-2 diabetes. Biochim Biophys Acta (2013) 0.94

Mitochondrial alteration in type 2 diabetes and obesity: an epigenetic link. Cell Cycle (2014) 0.94

Mutations in CYC1, encoding cytochrome c1 subunit of respiratory chain complex III, cause insulin-responsive hyperglycemia. Am J Hum Genet (2013) 0.94

Bioenergetic medicine. Br J Pharmacol (2014) 0.93

Origins of metabolic complications in obesity: adipose tissue and free fatty acid trafficking. Curr Opin Clin Nutr Metab Care (2011) 0.92

Adipose tissue mitochondrial dysfunction triggers a lipodystrophic syndrome with insulin resistance, hepatosteatosis, and cardiovascular complications. FASEB J (2014) 0.91

Aldose reductase-mediated phosphorylation of p53 leads to mitochondrial dysfunction and damage in diabetic platelets. Circulation (2014) 0.90

Increased hepatic de novo lipogenesis and mitochondrial efficiency in a model of obesity induced by diets rich in fructose. Eur J Nutr (2012) 0.89

Apolipoprotein O is mitochondrial and promotes lipotoxicity in heart. J Clin Invest (2014) 0.89

A multi-parametric workflow for the prioritization of mitochondrial DNA variants of clinical interest. Hum Genet (2015) 0.89

Recent findings on the health effects of omega-3 fatty acids and statins, and their interactions: do statins inhibit omega-3? BMC Med (2013) 0.88

Mitochondrial DNA copy number in peripheral blood is independently associated with visceral fat accumulation in healthy young adults. Int J Endocrinol (2014) 0.88

Alteration of energy substrates and ROS production in diabetic cardiomyopathy. Mediators Inflamm (2013) 0.88

Mitochondrial dysfunction in obesity: potential benefit and mechanism of Co-enzyme Q10 supplementation in metabolic syndrome. J Diabetes Metab Disord (2014) 0.88

Dipeptidyl peptidase-4 inhibition ameliorates Western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic mitochondrial function. Diabetes (2015) 0.87

Human platelets as a platform to monitor metabolic biomarkers using stable isotopes and LC-MS. Bioanalysis (2013) 0.87

Development of pharmacological strategies for mitochondrial disorders. Br J Pharmacol (2014) 0.87

Selective hepatic insulin resistance in a murine model heterozygous for a mitochondrial trifunctional protein defect. Hepatology (2013) 0.86

Mitochondrial plasticity in obesity and diabetes mellitus. Antioxid Redox Signal (2012) 0.86

Cellular and tissue expression of DAPIT, a phylogenetically conserved peptide. Eur J Histochem (2012) 0.85

Role of skeletal muscle mitochondrial density on exercise-stimulated lipid oxidation. Obesity (Silver Spring) (2011) 0.85

Elevated monoamine oxidase a binding during major depressive episodes is associated with greater severity and reversed neurovegetative symptoms. Neuropsychopharmacology (2013) 0.85

Effect of aging on islet beta-cell function and its mechanisms in Wistar rats. Age (Dordr) (2011) 0.85

MitoNEET-Parkin Effects in Pancreatic α- and β-Cells, Cellular Survival, and Intrainsular Cross Talk. Diabetes (2016) 0.85

The Ups and Downs of Insulin Resistance and Type 2 Diabetes: Lessons from Genomic Analyses in Humans. Curr Cardiovasc Risk Rep (2012) 0.84

Mitochondrial oxidative phosphorylation is impaired in patients with congenital lipodystrophy. J Clin Endocrinol Metab (2012) 0.82

Mitochondria, obesity and aging. Aging (Albany NY) (2012) 0.82

Fatty acid metabolism and the basis of brown adipose tissue function. Adipocyte (2015) 0.82

Redox homeostasis in pancreatic β cells. Oxid Med Cell Longev (2012) 0.82

Insulin resistance is associated with epigenetic and genetic regulation of mitochondrial DNA in obese humans. Clin Epigenetics (2015) 0.82

Ablation of PGC1 beta prevents mTOR dependent endoplasmic reticulum stress response. Exp Neurol (2012) 0.82

Variation and association to diabetes in 2000 full mtDNA sequences mined from an exome study in a Danish population. Eur J Hum Genet (2014) 0.81

Effects of intratracheally instilled laser printer-emitted engineered nanoparticles in a mouse model: A case study of toxicological implications from nanomaterials released during consumer use. NanoImpact (2016) 0.81

A mitochondrial therapeutic reverses visual decline in mouse models of diabetes. Dis Model Mech (2015) 0.80

Perinatal protein malnutrition affects mitochondrial function in adult and results in a resistance to high fat diet-induced obesity. PLoS One (2014) 0.80

Quercetin suppresses immune cell accumulation and improves mitochondrial gene expression in adipose tissue of diet-induced obese mice. Mol Nutr Food Res (2015) 0.79

Metabolic modeling of muscle metabolism identifies key reactions linked to insulin resistance phenotypes. Mol Metab (2015) 0.79

Protein Modifications as Manifestations of Hyperglycemic Glucotoxicity in Diabetes and Its Complications. Biochem Insights (2016) 0.79

Proteome-wide alterations on adipose tissue from obese patients as age-, diabetes- and gender-specific hallmarks. Sci Rep (2016) 0.79

Insulin Resistance in Human iPS Cells Reduces Mitochondrial Size and Function. Sci Rep (2016) 0.78

Modelling age-related metabolic disorders in the mouse. Mamm Genome (2014) 0.78

Mitochondrial DNA polymerase editing mutation, PolgD257A, reduces the diabetic phenotype of Akita male mice by suppressing appetite. Proc Natl Acad Sci U S A (2011) 0.78

Uric acid and transforming growth factor in fructose-induced production of reactive oxygen species in skeletal muscle. Nutr Rev (2016) 0.78

Dietary fucoxanthin increases metabolic rate and upregulated mRNA expressions of the PGC-1alpha network, mitochondrial biogenesis and fusion genes in white adipose tissues of mice. Mar Drugs (2014) 0.78

Inhibition of the mitochondrial enzyme ABAD restores the amyloid-β-mediated deregulation of estradiol. PLoS One (2011) 0.78

Mitochondrial function in ageing: coordination with signalling and transcriptional pathways. J Physiol (2015) 0.78

Mitochondria in the pathogenesis of diabetes: a proteomic view. Protein Cell (2012) 0.77

Emerging role of protein kinase C in energy homeostasis: A brief overview. World J Diabetes (2014) 0.77

Chronic glucocorticoid exposure-induced epididymal adiposity is associated with mitochondrial dysfunction in white adipose tissue of male C57BL/6J mice. PLoS One (2014) 0.77

Mitochondrial-associated metabolic disorders: foundations, pathologies and recent progress. Nutr Metab (Lond) (2013) 0.77

Combination of 5-aminolevulinic acid and ferrous ion reduces plasma glucose and hemoglobin A1c levels in Zucker diabetic fatty rats. FEBS Open Bio (2016) 0.77

The effect of smoking cessation pharmacotherapies on pancreatic beta cell function. Toxicol Appl Pharmacol (2012) 0.77

α-Lipoic acid ameliorates impaired glucose uptake in LYRM1 overexpressing 3T3-L1 adipocytes through the IRS-1/Akt signaling pathway. J Bioenerg Biomembr (2012) 0.77

Pharmacological Blockade of Cannabinoid CB1 Receptors in Diet-Induced Obesity Regulates Mitochondrial Dihydrolipoamide Dehydrogenase in Muscle. PLoS One (2015) 0.76

Phytochemical modulators of mitochondria: the search for chemopreventive agents and supportive therapeutics. Pharmaceuticals (Basel) (2014) 0.76

A Deafness- and Diabetes-associated tRNA Mutation Causes Deficient Pseudouridinylation at Position 55 in tRNAGlu and Mitochondrial Dysfunction. J Biol Chem (2016) 0.76

Chitooligosaccharide induces mitochondrial biogenesis and increases exercise endurance through the activation of Sirt1 and AMPK in rats. PLoS One (2012) 0.76

The Safety and Tolerability of 5-Aminolevulinic Acid Phosphate with Sodium Ferrous Citrate in Patients with Type 2 Diabetes Mellitus in Bahrain. J Diabetes Res (2016) 0.76

Mitochondrial Epigenetic Changes Link to Increased Diabetes Risk and Early-Stage Prediabetes Indicator. Oxid Med Cell Longev (2016) 0.76

Myocardial Structural and Biological Anomalies Induced by High Fat Diet in Psammomys obesus Gerbils. PLoS One (2016) 0.76

Mitochondrial targets for pharmacological intervention in human disease. J Proteome Res (2014) 0.76

Quercetin and Quercetin-Rich Red Onion Extract Alter Pgc-1α Promoter Methylation and Splice Variant Expression. PPAR Res (2017) 0.75

In situ assay of fatty acid β-oxidation by metabolite profiling following permeabilization of cell membranes. J Lipid Res (2012) 0.75

Articles cited by this

(truncated to the top 100)

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79

Prevalence of overweight and obesity in the United States, 1999-2004. JAMA (2006) 72.59

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med (2001) 56.11

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet (2003) 53.59

Identification and importance of brown adipose tissue in adult humans. N Engl J Med (2009) 20.57

Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell (1999) 19.48

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell (2006) 19.16

Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet (2006) 19.03

Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med (2004) 18.86

Cold-activated brown adipose tissue in healthy men. N Engl J Med (2009) 17.58

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A (2003) 17.10

Functional brown adipose tissue in healthy adults. N Engl J Med (2009) 16.22

Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med (2001) 14.48

Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature (2002) 14.37

A mitochondrial protein compendium elucidates complex I disease biology. Cell (2008) 13.51

PRDM16 controls a brown fat/skeletal muscle switch. Nature (2008) 13.08

How mitochondria produce reactive oxygen species. Biochem J (2009) 13.03

Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature (2004) 11.59

A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab (2009) 11.46

Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science (2003) 11.39

Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes (2002) 10.49

Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab (2007) 10.40

Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature (2006) 10.07

Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care (2001) 9.76

Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem (2002) 9.76

Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab (2008) 9.74

Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia (1993) 8.86

High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes (2009) 8.81

Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell (2004) 8.58

Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet (2000) 8.33

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology (2001) 8.09

Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab (2008) 7.97

Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet (1998) 7.89

Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet (1991) 7.87

TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med (2006) 7.75

Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell (2000) 7.26

Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab (2007) 6.83

Transcriptional control of brown fat determination by PRDM16. Cell Metab (2007) 6.79

Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab (2002) 6.79

Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med (2001) 6.79

Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria. Cell (2003) 6.77

Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest (1999) 6.73

Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev (2008) 6.57

Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc Natl Acad Sci U S A (2004) 6.53

Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev (2007) 6.53

Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet (1992) 6.28

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature (2000) 5.86

Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes (2000) 5.83

PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol (2005) 5.80

The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care (2005) 5.80

Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A (2001) 5.48

PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci U S A (2006) 5.28

Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes (2005) 5.22

Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell (2001) 5.13

Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest (2005) 4.81

The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue. FASEB J (2009) 4.78

Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science (2005) 4.76

Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages. Proc Natl Acad Sci U S A (2007) 4.69

Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab (2005) 4.65

Gestational diabetes mellitus. J Clin Invest (2005) 4.60

Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1alpha muscle-specific knock-out animals. J Biol Chem (2007) 4.58

GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha. Cell Metab (2006) 4.50

Birthweight and the risk for type 2 diabetes mellitus in adult women. Ann Intern Med (1999) 4.49

Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes (2003) 4.40

Maturation of iron-sulfur proteins in eukaryotes: mechanisms, connected processes, and diseases. Annu Rev Biochem (2008) 4.34

Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell (1999) 4.32

Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes (2005) 4.31

Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J Clin Invest (2008) 4.22

Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol (1999) 4.21

The key role of anaplerosis and cataplerosis for citric acid cycle function. J Biol Chem (2002) 4.20

Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta ), a novel PGC-1-related transcription coactivator associated with host cell factor. J Biol Chem (2001) 4.20

Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes (2000) 4.19

Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest (2004) 4.16

A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study. J Clin Invest (1962) 4.06

How obesity causes diabetes: not a tall tale. Science (2005) 3.89

A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes (2005) 3.84

Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell (2007) 3.82

Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol Syst Biol (2008) 3.82

Multilocular fat cells in WAT of CL-316243-treated rats derive directly from white adipocytes. Am J Physiol Cell Physiol (2000) 3.68

Nuclear receptor corepressor RIP140 regulates fat accumulation. Proc Natl Acad Sci U S A (2004) 3.67

Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev (1990) 3.64

Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance--a population-based twin study. Diabetologia (1999) 3.64

The biosynthesis and functional role of cardiolipin. Prog Lipid Res (2000) 3.60

Muscle-specific expression of PPARgamma coactivator-1alpha improves exercise performance and increases peak oxygen uptake. J Appl Physiol (1985) (2008) 3.54

Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis. Proc Natl Acad Sci U S A (1994) 3.46

Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J Biol Chem (2003) 3.45

Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med (1989) 3.38

FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets. J Clin Invest (2008) 3.25

Identification of novel candidate genes for type 2 diabetes from a genome-wide association scan in the Old Order Amish: evidence for replication from diabetes-related quantitative traits and from independent populations. Diabetes (2007) 3.22

PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol Cell (2009) 3.17

Mitochondrial dynamics and division in budding yeast. Trends Cell Biol (2002) 3.15

Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia (2007) 3.13

Acquirement of brown fat cell features by human white adipocytes. J Biol Chem (2003) 3.05

The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab (2007) 3.05

Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology (2008) 3.04

Abnormal glucose homeostasis in skeletal muscle-specific PGC-1alpha knockout mice reveals skeletal muscle-pancreatic beta cell crosstalk. J Clin Invest (2007) 3.02

Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am J Physiol (1990) 3.01

Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes (2009) 2.96

Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol Cell Biol (2003) 2.95

Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc Natl Acad Sci U S A (2003) 2.92

Articles by these authors

Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest (2004) 4.16

The vascular endothelium of the adipose tissue gives rise to both white and brown fat cells. Cell Metab (2012) 2.97

Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol Cell Biol (2003) 2.95

Cidea is associated with lipid droplets and insulin sensitivity in humans. Proc Natl Acad Sci U S A (2008) 2.71

TGF beta receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2. J Cell Biol (2002) 2.34

EHD2 and the novel EH domain binding protein EHBP1 couple endocytosis to the actin cytoskeleton. J Biol Chem (2003) 1.99

Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity. Circulation (2011) 1.97

Unconventional myosin Myo1c promotes membrane fusion in a regulated exocytic pathway. Mol Cell Biol (2004) 1.86

Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production. Am J Physiol Endocrinol Metab (2008) 1.79

Sorting of EGF and transferrin at the plasma membrane and by cargo-specific signaling to EEA1-enriched endosomes. J Cell Sci (2008) 1.70

Sequential roles for phosphatidylinositol 3-phosphate and Rab5 in tethering and fusion of early endosomes via their interaction with EEA1. J Biol Chem (2001) 1.59

Insulin stimulates membrane fusion and GLUT4 accumulation in clathrin coats on adipocyte plasma membranes. Mol Cell Biol (2007) 1.50

Structural basis for endosomal targeting by FYVE domains. J Biol Chem (2003) 1.50

What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes (2012) 1.35

Plasma membrane domains specialized for clathrin-mediated endocytosis in primary cells. J Biol Chem (2006) 1.31

Ian4 is required for mitochondrial integrity and T cell survival. Proc Natl Acad Sci U S A (2003) 1.19

Role of insulin action and cell size on protein expression patterns in adipocytes. J Biol Chem (2004) 1.17

The WD40 and FYVE domain containing protein 2 defines a class of early endosomes necessary for endocytosis. Proc Natl Acad Sci U S A (2006) 1.09

Rabenosyn-5 defines the fate of the transferrin receptor following clathrin-mediated endocytosis. Proc Natl Acad Sci U S A (2012) 1.08

Alternatively Activated M2 Macrophages Improve Autologous Fat Graft Survival in a Mouse Model through Induction of Angiogenesis. Plast Reconstr Surg (2015) 1.07

Structural basis for Rab GTPase recognition and endosome tethering by the C2H2 zinc finger of Early Endosomal Autoantigen 1 (EEA1). Proc Natl Acad Sci U S A (2010) 1.07

Paradoxical effect of mitochondrial respiratory chain impairment on insulin signaling and glucose transport in adipose cells. J Biol Chem (2008) 1.05

Evolutionarily conserved structural and functional roles of the FYVE domain. Biochem Soc Symp (2007) 1.00

Essential role of Ca2+/calmodulin in Early Endosome Antigen-1 localization. Mol Biol Cell (2003) 0.91

Regulation of the SHP-2 tyrosine phosphatase by a novel cholesterol- and cell confluence-dependent mechanism. J Biol Chem (2003) 0.91

Isoform-specific regulation of Akt signaling by the endosomal protein WDFY2. J Biol Chem (2010) 0.89

Adenylate kinase 2 links mitochondrial energy metabolism to the induction of the unfolded protein response. J Biol Chem (2010) 0.88

Antibodies to cell surface proteins redirect intracellular trafficking pathways. Exp Mol Pathol (2011) 0.86

CD14 deficiency impacts glucose homeostasis in mice through altered adrenal tone. PLoS One (2012) 0.83

Single point mutation in Rabenosyn-5 in a female with intractable seizures and evidence of defective endocytotic trafficking. Orphanet J Rare Dis (2014) 0.83

Human adipose tissue expansion in pregnancy is impaired in gestational diabetes mellitus. Diabetologia (2015) 0.78

Tensions rise and blood flows over dysfunctional fat. Circulation (2011) 0.77

Time-resolved ultrastructural detection of phosphatidylinositol 3-phosphate. J Histochem Cytochem (2010) 0.76